Trial Profile
Phase II Evaluation of FTI (R115777) (NSC 702818) [tipifarnib] in Treatment of Advanced Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Tipifarnib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 18 Sep 2005 New trial record.